<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:chebi fb="0" ids="6801">Metformin</z:chebi> is considered as the first-line drug therapy for the management of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Dipeptidyl peptidase-4 (DPP-4) inhibitors, by promoting insulin secretion and reducing glucagon secretion in a <z:chebi fb="105" ids="17234">glucose</z:chebi>-dependent manner, offer new opportunities for oral therapy after failure of <z:chebi fb="0" ids="6801">metformin</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>AREAS COVERED: An updated review of the literature demonstrates that saxagliptin, a DPP-4 inhibitor, and <z:chebi fb="0" ids="6801">metformin</z:chebi> may be administered together, separately or in fixed-dose combination (<z:chebi fb="17" ids="38848">FDC</z:chebi>), either as saxagliptin added to <z:chebi fb="0" ids="6801">metformin</z:chebi> or as initial combination in drug-naive patients </plain></SENT>
<SENT sid="3" pm="."><plain>Both compounds exert complementary pharmacodynamic actions leading to better improvement in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> control (fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, postprandial <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA1c) than either compound separately </plain></SENT>
<SENT sid="4" pm="."><plain>Adding saxagliptin to <z:chebi fb="0" ids="6801">metformin</z:chebi> monthotherapy results in a consistent, sustained and safe reduction in HbA1c levels </plain></SENT>
<SENT sid="5" pm="."><plain>Tolerance is excellent without <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> or <z:mp ids='MP_0005456'>weight gain</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>EXPERT OPINION: The combination saxaglitpin plus <z:chebi fb="0" ids="6801">metformin</z:chebi> may be used as first-line or second-line therapy in the management of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, especially as a valuable alternative to the classical <z:chebi fb="0" ids="6801">metformin</z:chebi>-<z:chebi fb="0" ids="26831">sulfonylurea</z:chebi> combination </plain></SENT>
</text></document>